Vega J D, Kanter K R, Lawrence E C
Division of Cardiothoracic Surgery/Department of Surgery, Emory University School of Medicine, Atlanta, USA.
J Med Assoc Ga. 1998 Apr;87(2):105-7.
Lung transplantation is a viable therapeutic option for patients with end-stage lung disease. Quality of life and survival are improved for most recipients. Donor availability remains an impediment to widespread application. The development of OB after lung transplantation continues to affect long-term survival. Clinical and basic science research will provide new strategies to further improve results.